1 Study Coverage 1.1 Anti-aging Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Anti-aging Drugs Market Size Growth Rate by Type 1.4.2 Dermal Fillers 1.4.3 Botulinum Toxin 1.2.4 Others 1.3 Market by Application 1.3.1 Global Anti-aging Drugs Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Beauty Parlor 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Anti-aging Drugs Sales Estimates and Forecasts 2016-2027 2.2 Global Anti-aging Drugs Revenue Estimates and Forecasts 2016-2027 2.3 Global Anti-aging Drugs Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Anti-aging Drugs Regions by Sales 2.4.1 Global Top Anti-aging Drugs Regions by Sales (2016-2021) 2.4.2 Global Top Anti-aging Drugs Regions by Sales (2022-2027) 2.5 Global Top Anti-aging Drugs Regions by Revenue 2.5.1 Global Top Anti-aging Drugs Regions by Revenue (2016-2021) 2.5.2 Global Top Anti-aging Drugs Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Anti-aging Drugs Sales by Manufacturers 3.1.1 Global Top Anti-aging Drugs Manufacturers by Sales (2016-2021) 3.1.2 Global Top Anti-aging Drugs Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Anti-aging Drugs Sales in 2020 3.2 Global Anti-aging Drugs Revenue by Manufacturers 3.2.1 Global Top Anti-aging Drugs Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Anti-aging Drugs Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Anti-aging Drugs Revenue in 2020 3.3 Global Anti-aging Drugs Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Anti-aging Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Anti-aging Drugs Sales by Type 4.1.1 Global Anti-aging Drugs Historical Sales by Type (2016-2021) 4.1.2 Global Anti-aging Drugs Forecasted Sales by Type (2022-2027) 4.1.3 Global Anti-aging Drugs Sales Market Share by Type (2016-2027) 4.2 Global Anti-aging Drugs Revenue by Type 4.2.1 Global Anti-aging Drugs Historical Revenue by Type (2016-2021) 4.2.2 Global Anti-aging Drugs Forecasted Revenue by Type (2022-2027) 4.2.3 Global Anti-aging Drugs Revenue Market Share by Type (2016-2027) 4.3 Global Anti-aging Drugs Price by Type 4.3.1 Global Anti-aging Drugs Price by Type (2016-2021) 4.3.2 Global Anti-aging Drugs Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Anti-aging Drugs Sales by Application 5.1.1 Global Anti-aging Drugs Historical Sales by Application (2016-2021) 5.1.2 Global Anti-aging Drugs Forecasted Sales by Application (2022-2027) 5.1.3 Global Anti-aging Drugs Sales Market Share by Application (2016-2027) 5.2 Global Anti-aging Drugs Revenue by Application 5.2.1 Global Anti-aging Drugs Historical Revenue by Application (2016-2021) 5.2.2 Global Anti-aging Drugs Forecasted Revenue by Application (2022-2027) 5.2.3 Global Anti-aging Drugs Revenue Market Share by Application (2016-2027) 5.3 Global Anti-aging Drugs Price by Application 5.3.1 Global Anti-aging Drugs Price by Application (2016-2021) 5.3.2 Global Anti-aging Drugs Price Forecast by Application (2022-2027) 6 North America 6.1 North America Anti-aging Drugs Market Size by Type 6.1.1 North America Anti-aging Drugs Sales by Type (2016-2027) 6.1.2 North America Anti-aging Drugs Revenue by Type (2016-2027) 6.2 North America Anti-aging Drugs Market Size by Application 6.2.1 North America Anti-aging Drugs Sales by Application (2016-2027) 6.2.2 North America Anti-aging Drugs Revenue by Application (2016-2027) 6.3 North America Anti-aging Drugs Market Size by Country 6.3.1 North America Anti-aging Drugs Sales by Country (2016-2027) 6.3.2 North America Anti-aging Drugs Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Anti-aging Drugs Market Size by Type 7.1.1 Europe Anti-aging Drugs Sales by Type (2017-2027) 7.1.2 Europe Anti-aging Drugs Revenue by Type (2017-2027) 7.2 Europe Anti-aging Drugs Market Size by Application 7.2.1 Europe Anti-aging Drugs Sales by Application (2017-2027) 7.2.2 Europe Anti-aging Drugs Revenue by Application (2017-2027) 7.3 Europe Anti-aging Drugs Market Size by Country 7.3.1 Europe Anti-aging Drugs Sales by Country (2017-2027) 7.3.2 Europe Anti-aging Drugs Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Anti-aging Drugs Market Size by Type 8.1.1 Asia Pacific Anti-aging Drugs Sales by Type (2018-2027) 8.1.2 Asia Pacific Anti-aging Drugs Revenue by Type (2018-2027) 8.2 Asia Pacific Anti-aging Drugs Market Size by Application 8.2.1 Asia Pacific Anti-aging Drugs Sales by Application (2018-2027) 8.2.2 Asia Pacific Anti-aging Drugs Revenue by Application (2018-2027) 8.3 Asia Pacific Anti-aging Drugs Market Size by Region 8.3.1 Asia Pacific Anti-aging Drugs Sales by Region (2018-2027) 8.3.2 Asia Pacific Anti-aging Drugs Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Anti-aging Drugs Market Size by Type 9.1.1 Latin America Anti-aging Drugs Sales by Type (2019-2027) 9.1.2 Latin America Anti-aging Drugs Revenue by Type (2019-2027) 9.2 Latin America Anti-aging Drugs Market Size by Application 9.2.1 Latin America Anti-aging Drugs Sales by Application (2019-2027) 9.2.2 Latin America Anti-aging Drugs Revenue by Application (2019-2027) 9.3 Latin America Anti-aging Drugs Market Size by Country 9.3.1 Latin America Anti-aging Drugs Sales by Country (2019-2027) 9.3.2 Latin America Anti-aging Drugs Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Anti-aging Drugs Market Size by Type 6.1.1 Middle East and Africa Anti-aging Drugs Sales by Type (2016-2027) 6.1.2 Middle East and Africa Anti-aging Drugs Revenue by Type (2016-2027) 6.2 Middle East and Africa Anti-aging Drugs Market Size by Application 6.2.1 Middle East and Africa Anti-aging Drugs Sales by Application (2016-2027) 6.2.2 Middle East and Africa Anti-aging Drugs Revenue by Application (2016-2027) 6.3 Middle East and Africa Anti-aging Drugs Market Size by Country 6.3.1 Middle East and Africa Anti-aging Drugs Sales by Country (2016-2027) 6.3.2 Middle East and Africa Anti-aging Drugs Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 UAE 11 Company Profiles 11.1 Allergan 11.1.1 Allergan Corporation Information 11.1.2 Allergan Overview 11.1.3 Allergan Anti-aging Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Allergan Anti-aging Drugs Product Description 11.1.5 Allergan Related Developments 11.2 Galderma 11.2.1 Galderma Corporation Information 11.2.2 Galderma Overview 11.2.3 Galderma Anti-aging Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Galderma Anti-aging Drugs Product Description 11.2.5 Galderma Related Developments 11.3 LG Life Science 11.3.1 LG Life Science Corporation Information 11.3.2 LG Life Science Overview 11.3.3 LG Life Science Anti-aging Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 LG Life Science Anti-aging Drugs Product Description 11.3.5 LG Life Science Related Developments 11.4 Merz Pharma 11.4.1 Merz Pharma Corporation Information 11.4.2 Merz Pharma Overview 11.4.3 Merz Pharma Anti-aging Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Merz Pharma Anti-aging Drugs Product Description 11.4.5 Merz Pharma Related Developments 11.5 Medytox 11.5.1 Medytox Corporation Information 11.5.2 Medytox Overview 11.5.3 Medytox Anti-aging Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Medytox Anti-aging Drugs Product Description 11.5.5 Medytox Related Developments 11.6 Hugel 11.6.1 Hugel Corporation Information 11.6.2 Hugel Overview 11.6.3 Hugel Anti-aging Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Hugel Anti-aging Drugs Product Description 11.6.5 Hugel Related Developments 11.7 IMEIK 11.7.1 IMEIK Corporation Information 11.7.2 IMEIK Overview 11.7.3 IMEIK Anti-aging Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 IMEIK Anti-aging Drugs Product Description 11.7.5 IMEIK Related Developments 11.8 Haohai Bio 11.8.1 Haohai Bio Corporation Information 11.8.2 Haohai Bio Overview 11.8.3 Haohai Bio Anti-aging Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Haohai Bio Anti-aging Drugs Product Description 11.8.5 Haohai Bio Related Developments 11.9 Daewoong Pharmaceutical 11.9.1 Daewoong Pharmaceutical Corporation Information 11.9.2 Daewoong Pharmaceutical Overview 11.9.3 Daewoong Pharmaceutical Anti-aging Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Daewoong Pharmaceutical Anti-aging Drugs Product Description 11.9.5 Daewoong Pharmaceutical Related Developments 11.10 Bloomage 11.10.1 Bloomage Corporation Information 11.10.2 Bloomage Overview 11.10.3 Bloomage Anti-aging Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 Bloomage Anti-aging Drugs Product Description 11.10.5 Bloomage Related Developments 11.1 Allergan 11.1.1 Allergan Corporation Information 11.1.2 Allergan Overview 11.1.3 Allergan Anti-aging Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Allergan Anti-aging Drugs Product Description 11.1.5 Allergan Related Developments 11.12 SciVision Biotech 11.12.1 SciVision Biotech Corporation Information 11.12.2 SciVision Biotech Overview 11.12.3 SciVision Biotech Anti-aging Drugs Sales, Price, Revenue and Gross Margin (2016-2021) 11.12.4 SciVision Biotech Product Description 11.12.5 SciVision Biotech Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Anti-aging Drugs Value Chain Analysis 12.2 Anti-aging Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Anti-aging Drugs Production Mode & Process 12.4 Anti-aging Drugs Sales and Marketing 12.4.1 Anti-aging Drugs Sales Channels 12.4.2 Anti-aging Drugs Distributors 12.5 Anti-aging Drugs Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Anti-aging Drugs Industry Trends 13.2 Anti-aging Drugs Market Drivers 13.3 Anti-aging Drugs Market Challenges 13.4 Anti-aging Drugs Market Restraints 14 Key Findings in The Global Anti-aging Drugs Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Anti-aging Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Dermal Fillers Table 3. Major Manufacturers of Botulinum Toxin Table 4. Major Manufacturers of Others Table 5. Global Anti-aging Drugs Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Anti-aging Drugs Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Anti-aging Drugs Sales by Region (2016-2021) & (K Units) Table 8. Global Anti-aging Drugs Sales Market Share by Region (2016-2021) Table 9. Global Anti-aging Drugs Sales by Region (2016-2021) & (K Units) Table 10. Global Anti-aging Drugs Sales Market Share by Region (2022-2027) Table 11. Global Anti-aging Drugs Revenue by Region (2016-2021) & (US$ Million) Table 12. Global Anti-aging Drugs Revenue Market Share by Region (2016-2021) Table 13. Global Anti-aging Drugs Revenue by Region (2022-2027) & (US$ Million) Table 14. Global Anti-aging Drugs Revenue Market Share by Region (2022-2027) Table 15. Global Anti-aging Drugs Sales by Manufacturers (2016-2021) & (K Units) Table 16. Global Anti-aging Drugs Sales Share by Manufacturers (2016-2021) Table 17. Global Anti-aging Drugs Revenue by Manufacturers (2016-2021) & (US$ Million) Table 18. Global Anti-aging Drugs Revenue Share by Manufacturers (2016-2021) Table 19. Anti-aging Drugs Price by Manufacturers 2016-2021 (US$/Unit) Table 20. Global Anti-aging Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Anti-aging Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2020) Table 22. Anti-aging Drugs Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Anti-aging Drugs Product Offered Table 24. Date of Manufacturers Enter into Anti-aging Drugs Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Anti-aging Drugs Sales by Type (2016-2021) & (K Units) Table 27. Global Anti-aging Drugs Sales by Type (2022-2027) & (K Units) Table 28. Global Anti-aging Drugs Sales Share by Type (2016-2021) Table 29. Global Anti-aging Drugs Sales Share by Type (2022-2027) Table 30. Global Anti-aging Drugs Revenue by Type (2016-2021) & (US$ Million) Table 31. Global Anti-aging Drugs Revenue by Type (2022-2027) & (US$ Million) Table 32. Global Anti-aging Drugs Revenue Share by Type (2016-2021) Table 33. Global Anti-aging Drugs Revenue Share by Type (2022-2027) Table 34. Anti-aging Drugs Price by Type (2016-2021) & (US$/Unit) Table 35. Global Anti-aging Drugs Price Forecast by Type (2022-2027) & (US$/Unit) Table 36. Global Anti-aging Drugs Sales by Application (2016-2021) & (K Units) Table 37. Global Anti-aging Drugs Sales by Application (2022-2027) & (K Units) Table 38. Global Anti-aging Drugs Sales Share by Application (2016-2021) Table 39. Global Anti-aging Drugs Sales Share by Application (2022-2027) Table 40. Global Anti-aging Drugs Revenue by Application (2016-2021) & (US$ Million) Table 41. Global Anti-aging Drugs Revenue by Application (2022-2027) & (US$ Million) Table 42. Global Anti-aging Drugs Revenue Share by Application (2016-2021) Table 43. Global Anti-aging Drugs Revenue Share by Application (2022-2027) Table 44. Anti-aging Drugs Price by Application (2016-2021) & (US$/Unit) Table 45. Global Anti-aging Drugs Price Forecast by Application (2022-2027) & (US$/Unit) Table 46. North America Anti-aging Drugs Sales by Type (2016-2021) & (K Units) Table 47. North America Anti-aging Drugs Sales by Type (2022-2027) & (K Units) Table 48. North America Anti-aging Drugs Revenue by Type (2016-2021) & (US$ Million) Table 49. North America Anti-aging Drugs Revenue by Type (2022-2027) & (US$ Million) Table 50. North America Anti-aging Drugs Sales by Application (2016-2021) & (K Units) Table 51. North America Anti-aging Drugs Sales by Application (2022-2027) & (K Units) Table 52. North America Anti-aging Drugs Revenue by Application (2016-2021) & (US$ Million) Table 53. North America Anti-aging Drugs Revenue by Application (2022-2027) & (US$ Million) Table 54. North America Anti-aging Drugs Sales by Country (2016-2021) & (K Units) Table 55. North America Anti-aging Drugs Sales by Country (2022-2027) & (K Units) Table 56. North America Anti-aging Drugs Revenue by Country (2016-2021) & (US$ Million) Table 57. North America Anti-aging Drugs Revenue by Country (2022-2027) & (US$ Million) Table 58. Europe Anti-aging Drugs Sales by Type (2016-2021) & (K Units) Table 59. Europe Anti-aging Drugs Sales by Type (2022-2027) & (K Units) Table 60. Europe Anti-aging Drugs Revenue by Type (2016-2021) & (US$ Million) Table 61. Europe Anti-aging Drugs Revenue by Type (2022-2027) & (US$ Million) Table 62. Europe Anti-aging Drugs Sales by Application (2016-2021) & (K Units) Table 63. Europe Anti-aging Drugs Sales by Application (2022-2027) & (K Units) Table 64. Europe Anti-aging Drugs Revenue by Application (2016-2021) & (US$ Million) Table 65. Europe Anti-aging Drugs Revenue by Application (2022-2027) & (US$ Million) Table 66. Europe Anti-aging Drugs Sales by Country (2016-2021) & (K Units) Table 67. Europe Anti-aging Drugs Sales by Country (2022-2027) & (K Units) Table 68. Europe Anti-aging Drugs Revenue by Country (2016-2021) & (US$ Million) Table 69. Europe Anti-aging Drugs Revenue by Country (2022-2027) & (US$ Million) Table 70. Asia Pacific Anti-aging Drugs Sales by Type (2016-2021) & (K Units) Table 71. Asia Pacific Anti-aging Drugs Sales by Type (2022-2027) & (K Units) Table 72. Asia Pacific Anti-aging Drugs Revenue by Type (2016-2021) & (US$ Million) Table 73. Asia Pacific Anti-aging Drugs Revenue by Type (2022-2027) & (US$ Million) Table 74. Asia Pacific Anti-aging Drugs Sales by Application (2016-2021) & (K Units) Table 75. Asia Pacific Anti-aging Drugs Sales by Application (2022-2027) & (K Units) Table 76. Asia Pacific Anti-aging Drugs Revenue by Application (2016-2021) & (US$ Million) Table 77. Asia Pacific Anti-aging Drugs Revenue by Application (2022-2027) & (US$ Million) Table 78. Asia Pacific Anti-aging Drugs Sales by Region (2016-2021) & (K Units) Table 79. Asia Pacific Anti-aging Drugs Sales by Region (2022-2027) & (K Units) Table 80. Asia Pacific Anti-aging Drugs Revenue by Region (2016-2021) & (US$ Million) Table 81. Asia Pacific Anti-aging Drugs Revenue by Region (2022-2027) & (US$ Million) Table 82. Latin America Anti-aging Drugs Sales by Type (2016-2021) & (K Units) Table 83. Latin America Anti-aging Drugs Sales by Type (2022-2027) & (K Units) Table 84. Latin America Anti-aging Drugs Revenue by Type (2016-2021) & (US$ Million) Table 85. Latin America Anti-aging Drugs Revenue by Type (2022-2027) & (US$ Million) Table 86. Latin America Anti-aging Drugs Sales by Application (2016-2021) & (K Units) Table 87. Latin America Anti-aging Drugs Sales by Application (2022-2027) & (K Units) Table 88. Latin America Anti-aging Drugs Revenue by Application (2016-2021) & (US$ Million) Table 89. Latin America Anti-aging Drugs Revenue by Application (2022-2027) & (US$ Million) Table 90. Latin America Anti-aging Drugs Sales by Country (2016-2021) & (K Units) Table 91. Latin America Anti-aging Drugs Sales by Country (2022-2027) & (K Units) Table 92. Latin America Anti-aging Drugs Revenue by Country (2016-2021) & (US$ Million) Table 93. Latin America Anti-aging Drugs Revenue by Country (2022-2027) & (US$ Million) Table 94. Middle East and Africa Anti-aging Drugs Sales by Type (2016-2021) & (K Units) Table 95. Middle East and Africa Anti-aging Drugs Sales by Type (2022-2027) & (K Units) Table 96. Middle East and Africa Anti-aging Drugs Revenue by Type (2016-2021) & (US$ Million) Table 97. Middle East and Africa Anti-aging Drugs Revenue by Type (2022-2027) & (US$ Million) Table 98. Middle East and Africa Anti-aging Drugs Sales by Application (2016-2021) & (K Units) Table 99. Middle East and Africa Anti-aging Drugs Sales by Application (2022-2027) & (K Units) Table 100. Middle East and Africa Anti-aging Drugs Revenue by Application (2016-2021) & (US$ Million) Table 101. Middle East and Africa Anti-aging Drugs Revenue by Application (2022-2027) & (US$ Million) Table 102. Middle East and Africa Anti-aging Drugs Sales by Country (2016-2021) & (K Units) Table 103. Middle East and Africa Anti-aging Drugs Sales by Country (2022-2027) & (K Units) Table 104. Middle East and Africa Anti-aging Drugs Revenue by Country (2016-2021) & (US$ Million) Table 105. Middle East and Africa Anti-aging Drugs Revenue by Country (2022-2027) & (US$ Million) Table 106. Allergan Corporation Information Table 107. Allergan Description and Major Businesses Table 108. Allergan Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 109. Allergan Anti-aging Drugs Product Table 110. Allergan Recent Developments Table 111. Galderma Corporation Information Table 112. Galderma Description and Major Businesses Table 113. Galderma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 114. Galderma Anti-aging Drugs Product Table 115. Galderma Recent Developments Table 116. LG Life Science Corporation Information Table 117. LG Life Science Description and Major Businesses Table 118. LG Life Science Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 119. LG Life Science Anti-aging Drugs Product Table 120. LG Life Science Recent Developments Table 121. Merz Pharma Corporation Information Table 122. Merz Pharma Description and Major Businesses Table 123. Merz Pharma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 124. Merz Pharma Anti-aging Drugs Product Table 125. Merz Pharma Recent Developments Table 126. Medytox Corporation Information Table 127. Medytox Description and Major Businesses Table 128. Medytox Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 129. Medytox Anti-aging Drugs Product Table 130. Medytox Recent Developments Table 131. Hugel Corporation Information Table 132. Hugel Description and Major Businesses Table 133. Hugel Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 134. Hugel Anti-aging Drugs Product Table 135. Hugel Recent Developments Table 136. IMEIK Corporation Information Table 137. IMEIK Description and Major Businesses Table 138. IMEIK Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 139. IMEIK Anti-aging Drugs Product Table 140. IMEIK Recent Developments Table 141. Haohai Bio Corporation Information Table 142. Haohai Bio Description and Major Businesses Table 143. Haohai Bio Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 144. Haohai Bio Anti-aging Drugs Product Table 145. Haohai Bio Recent Developments Table 146. Daewoong Pharmaceutical Corporation Information Table 147. Daewoong Pharmaceutical Description and Major Businesses Table 148. Daewoong Pharmaceutical Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 149. Daewoong Pharmaceutical Anti-aging Drugs Product Table 150. Daewoong Pharmaceutical Recent Developments Table 151. Bloomage Corporation Information Table 152. Bloomage Description and Major Businesses Table 153. Bloomage Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 154. Bloomage Anti-aging Drugs Product Table 155. Bloomage Recent Developments Table 156. Suneva Medical Corporation Information Table 157. Suneva Medical Description and Major Businesses Table 158. Suneva Medical Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 159. Suneva Medical Anti-aging Drugs Product Table 160. Suneva Medical Recent Developments Table 161. SciVision Biotech Corporation Information Table 162. SciVision Biotech Description and Major Businesses Table 163. SciVision Biotech Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 164. SciVision Biotech Anti-aging Drugs Product Table 165. SciVision Biotech Recent Developments Table 166. Key Raw Materials Lists Table 167. Raw Materials Key Suppliers Lists Table 168. Anti-aging Drugs Distributors List Table 169. Anti-aging Drugs Customers List Table 170. Anti-aging Drugs Market Trends Table 171. Anti-aging Drugs Market Drivers Table 172. Anti-aging Drugs Market Challenges Table 173. Anti-aging Drugs Market Restraints Table 174. Research Programs/Design for This Report Table 175. Key Data Information from Secondary Sources Table 176. Key Data Information from Primary Sources List of Figures Figure 1. Anti-aging Drugs Product Picture Figure 2. Global Anti-aging Drugs Market Share by Type in 2020 & 2027 Figure 3. Dermal Fillers Product Picture Figure 4. Botulinum Toxin Product Picture Figure 5. Others Product Picture Figure 6. Global Anti-aging Drugs Sales Market Share by Application in 2020 & 2027 Figure 7. Hospital Figure 8. Beauty Parlor Figure 9. Others Figure 10. Anti-aging Drugs Report Years Considered Figure 11. Global Anti-aging Drugs Sales 2016-2027 (K Units) Figure 12. Global Anti-aging Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Anti-aging Drugs Revenue 2016-2027 (US$ Million) Figure 14. Global Anti-aging Drugs Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 15. Global Anti-aging Drugs Sales Market Share by Region (2016-2021) Figure 16. Global Anti-aging Drugs Sales Market Share by Region (2022-2027) Figure 17. North America Anti-aging Drugs Sales YoY (2016-2027) & (K Units) Figure 18. North America Anti-aging Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 19. Europe Anti-aging Drugs Sales YoY (2016-2027) & (K Units) Figure 20. Europe Anti-aging Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 21. Asia-Pacific Anti-aging Drugs Sales YoY (2016-2027) & (K Units) Figure 22. Asia-Pacific Anti-aging Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 23. Latin America Anti-aging Drugs Sales YoY (2016-2027) & (K Units) Figure 24. Latin America Anti-aging Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 25. Middle East & Africa Anti-aging Drugs Sales YoY (2016-2027) & (K Units) Figure 26. Middle East & Africa Anti-aging Drugs Revenue YoY (2016-2027) & (US$ Million) Figure 27. The Top 10 and Top 5 Players Market Share by Anti-aging Drugs Sales in 2020 Figure 28. The Top 10 and Top 5 Players Market Share by Anti-aging Drugs Revenue in 2020 Figure 29. Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 30. Global Anti-aging Drugs Sales Market Share by Type (2016-2027) Figure 31. Global Anti-aging Drugs Revenue Market Share by Type (2016-2027) Figure 32. Global Anti-aging Drugs Sales Market Share by Application (2016-2027) Figure 33. Global Anti-aging Drugs Revenue Market Share by Application (2016-2027) Figure 34. North America Anti-aging Drugs Sales Market Share by Type (2016-2027) Figure 35. North America Anti-aging Drugs Revenue Market Share by Type (2016-2027) Figure 36. North America Anti-aging Drugs Sales Market Share by Application (2016-2027) Figure 37. North America Anti-aging Drugs Revenue Market Share by Application (2016-2027) Figure 38. North America Anti-aging Drugs Sales Share by Country (2016-2027) Figure 39. North America Anti-aging Drugs Revenue Share by Country (2016-2027) Figure 40. U.S. Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 41. Canada Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 42. Europe Anti-aging Drugs Sales Market Share by Type (2016-2027) Figure 43. Europe Anti-aging Drugs Revenue Market Share by Type (2016-2027) Figure 44. Europe Anti-aging Drugs Sales Market Share by Application (2016-2027) Figure 45. Europe Anti-aging Drugs Revenue Market Share by Application (2016-2027) Figure 46. Europe Anti-aging Drugs Sales Share by Country (2016-2027) Figure 47. Europe Anti-aging Drugs Revenue Share by Country (2016-2027) Figure 48. Germany Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 49. France Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 50. U.K. Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 51. Italy Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 52. Russia Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 53. Asia Pacific Anti-aging Drugs Sales Market Share by Type (2016-2027) Figure 54. Asia Pacific Anti-aging Drugs Revenue Market Share by Type (2016-2027) Figure 55. Asia Pacific Anti-aging Drugs Sales Market Share by Application (2016-2027) Figure 56. Asia Pacific Anti-aging Drugs Revenue Market Share by Application (2016-2027) Figure 57. Asia Pacific Anti-aging Drugs Sales Share by Region (2016-2027) Figure 58. Asia Pacific Anti-aging Drugs Revenue Share by Region (2016-2027) Figure 59. China Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 60. Japan Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 61. South Korea Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 62. India Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 63. Australia Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 64. Taiwan Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 65. Indonesia Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 66. Thailand Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 67. Malaysia Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 68. Philippines Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 69. Latin America Anti-aging Drugs Sales Market Share by Type (2016-2027) Figure 70. Latin America Anti-aging Drugs Revenue Market Share by Type (2016-2027) Figure 71. Latin America Anti-aging Drugs Sales Market Share by Application (2016-2027) Figure 72. Latin America Anti-aging Drugs Revenue Market Share by Application (2016-2027) Figure 73. Latin America Anti-aging Drugs Sales Share by Country (2016-2027) Figure 74. Latin America Anti-aging Drugs Revenue Share by Country (2016-2027) Figure 75. Mexico Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 76. Brazil Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 77. Argentina Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 78. Middle East and Africa Anti-aging Drugs Sales Market Share by Type (2016-2027) Figure 79. Middle East and Africa Anti-aging Drugs Revenue Market Share by Type (2016-2027) Figure 80. Middle East and Africa Anti-aging Drugs Sales Market Share by Application (2016-2027) Figure 81. Middle East and Africa Anti-aging Drugs Revenue Market Share by Application (2016-2027) Figure 82. Middle East and Africa Anti-aging Drugs Sales Share by Country (2016-2027) Figure 83. Middle East and Africa Anti-aging Drugs Revenue Share by Country (2016-2027) Figure 84. Turkey Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 85. Saudi Arabia Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 86. UAE Anti-aging Drugs Revenue (2016-2027) & (US$ Million) Figure 87. Anti-aging Drugs Value Chain Figure 88. Anti-aging Drugs Production Process Figure 89. Channels of Distribution Figure 90. Distributors Profiles Figure 91. Bottom-up and Top-down Approaches for This Report Figure 92. Data Triangulation Figure 93. Key Executives Interviewed

Allergan Galderma LG Life Science Merz Pharma Medytox Hugel IMEIK Haohai Bio Daewoong Pharmaceutical Bloomage Suneva Medical SciVision Biotech